SPARCL1 and non-small cell lung carcinoma: This gene was originally shown to be downregulated in human non-small cell lung cancer and subsequent reports indicated that downregulation of SPARCL1 also occurs in prostate and colon carcinomas (Bendik et al, 1998; Isler et al, 2001).